Press release
Global Anti-Depressant Drugs Market Expected to Experience Incremental Growth by 2030, According to DelveInsight | AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer, more
Anti-Depressant Drugs Market
DelveInsight's "Anti-Depressant Drugs Market Insights, Competitive Landscape, and Market Forecast - 2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Anti-Depressant Drugs companies actively working in the market.
Request for sample report @ Anti-Depressant Drugs Market - https://www.delveinsight.com/report-store/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Anti-Depressant Drugs Market are:
• As per DelveInsight estimates, North America is anticipated to dominate the global anti-depressant drugs market during the forecast period.
• Notable anti-depressant drugs companies such as AbbVie Inc., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Organon group of companies, Takeda Pharmaceutical Company Limited, Novartis AG, Biogen Inc., Sage Therapeutics, Axsome Therapeutics, Fabre-Kramer Pharmaceuticals, Inc., Lupin, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., and several others, are currently operating in the anti-depressant drugs market.
• In September 2023, the FDA approved a new drug Exxua by Fabre-Kramer Pharmaceuticals to treat major depressive disorder in adults.
• In August 2023, Biogen Inc. and Sage Therapeutics, Inc. announced that the US Food and Drug Administration (FDA) has approved ZURZUVAE™ (zuranolone) 50 mg for adults with postpartum depression (PPD).
• In August 2022, the FDA approved Auvelity which is an extended-release dextromethorphan/bupropion tablet intended for the treatment of major depressive disorder in adults.
Anti-Depressant Drugs Overview
Antidepressant medications are fundamental in treating depression by adjusting neurotransmitter levels in the brain. These drugs, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), help regulate mood-related chemicals to reduce depressive symptoms. For many, antidepressants provide a way to manage the overwhelming effects of depression, improving their overall well-being and restoring a sense of normalcy.
However, the effectiveness of these medications can differ greatly between individuals, often requiring a trial-and-error approach. They may also cause side effects, making close medical supervision essential. Despite these complexities, antidepressants remain crucial in helping millions worldwide cope with depression.
To know more about why North America is leading the market growth in the Anti-Depressant Drugs market, get a snapshot of the report Anti-Depressant Drugs Market Trends - https://www.delveinsight.com/sample-request/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Anti-Depressant Drugs Market Insights
In 2023, North America dominated the antidepressant drugs market, driven by factors like the growing prevalence of mental health disorders, a strong healthcare system, and continuous advancements in product development. According to the National Institute of Mental Health (NIMH), 52.9 million Americans experienced mental illness in 2020, with 21 million suffering from major depressive episodes, reflecting the high demand for antidepressant medications.
The antidepressants market is expected to expand further between 2024 and 2030, supported by new drug approvals. For instance, in September 2023, Fabre-Kramer Pharmaceuticals gained FDA approval for Exxua, a treatment for major depressive disorder with fewer side effects than existing drugs. This underscores the industry's commitment to developing better, more tolerable treatments.
Globally, mental health disorders, including depression and anxiety, affected 301 million people in 2019, according to the World Health Organization. Ongoing research and clinical trials, such as Autobahn Therapeutics' ABX-002 for major depressive disorder, are poised to drive future market growth.
However, challenges like regulatory requirements, drug safety concerns, and the stigma surrounding mental illness may hinder market expansion. Despite these barriers, North America's strong healthcare infrastructure and innovation make it a key player in the global antidepressant market.
Recent Developments in the Anti-Depressant Drugs Market Report
• In September 2023, the FDA approved a new drug Exxua by Fabre-Kramer Pharmaceuticals to treat major depressive disorder in adults.
• In August 2023, Biogen Inc. and Sage Therapeutics, Inc. announced that the US Food and Drug Administration (FDA) has approved ZURZUVAE™ (zuranolone) 50 mg for adults with postpartum depression (PPD).
To read more about the latest highlights related to Anti-Depressant Drugs, get a snapshot of the key highlights entailed in the Anti-Depressant Drugs Treatment Landscape - https://www.delveinsight.com/report-store/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Players in the Anti-Depressant Drugs Market
Some of the key market players operating in the Anti-Depressant Drugs market include- AbbVie Inc., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Organon group of companies, Takeda Pharmaceutical Company Limited, Novartis AG, Biogen Inc., Sage Therapeutics, Axsome Therapeutics, Fabre-Kramer Pharmaceuticals, Inc., Lupin, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., among others
Scope of the Anti-Depressant Drugs Market Report
• Coverage: Global
• Study Period: 2021-2030
• Anti-Depressant Drugs Market Segmentation By Drug Type: Selective Serotonin Reuptake Inhibitors (SSRI), Selective-norepinephrine Reuptake Inhibitors (SNRI), Tricyclic Antidepressants (TCA), Monoamine Oxidase Inhibitors (MAOI), and Others
• Anti-Depressant Drugs Market Segmentation By Application: Major Depressive Disorder (MDD), Obsessive-compulsive Disorder (OCD), General Anxiety Disorder (GAD), Panic Disorder (PD), and Others
• Anti-Depressant Drugs Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Anti-Depressant Drugs Companies: AbbVie Inc., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Organon group of companies, Takeda Pharmaceutical Company Limited, Novartis AG, Biogen Inc., Sage Therapeutics, Axsome Therapeutics, Fabre-Kramer Pharmaceuticals, Inc., Lupin, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., among others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Anti-Depressant Drugs KOL - Views and Insights
To keep up with the anti-depressant drugs market trends, we take KOLs and SME's opinions working in the Anti-Depressant Drugs domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging Anti-Depressant Drugs market trends. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Reasons To Buy Anti-Depressant Drugs Market Report:
• The Anti-Depressant Drugs market report will help develop business strategies by understanding the latest trends and changing treatment dynamics driving the Anti-Depressant Drugs Market.
• To understand the existing Anti-Depressant Drugs market opportunity in varying geographies and the growth potential over the coming years.
• Identifying strong upcoming players in the Anti-Depressant Drugs market will help devise strategies that will help get ahead of competitors.
• Detailed analysis and ranking of potential current and emerging therapies under the conjoint analysis section to provide visibility around leading classes.
• To understand the perspective of Key Opinion Leaders around the accessibility, acceptability, and compliance-related challenges of existing treatment to overcome barriers in the future.
• Detailed insights on the unmet needs of the existing Anti-Depressant Drugs market so that the upcoming players can strengthen their development and launch strategy.
Which key players in the Anti-Depressant Drugs market are set to emerge as the trendsetter explore @ Anti-Depressant Drugs Market Landscape - https://www.delveinsight.com/sample-request/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Anti-Depressant Drugs Market Report Introduction
2. Anti-Depressant Drugs Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Anti-Depressant Drugs Market Key Factors Analysis
6. Anti-Depressant Drugs Market Porter's Five Forces Analysis
7. Anti-Depressant Drugs Market Layout
8. Anti-Depressant Drugs Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
Interested in knowing how the Anti-Depressant Drugs market will grow by 2030? Click to get a snapshot of the Anti-Depressant Drugs Market Forecast- https://www.delveinsight.com/sample-request/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Cardiac Resynchronization Therapy Device Market: https://www.delveinsight.com/report-store/cardiac-resynchronization-therapy-market
• Chronic Insomnia Market: https://www.delveinsight.com/report-store/insomnia-market
• Deep Vein Thrombosis Market: https://www.delveinsight.com/report-store/deep-vein-thrombosis-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Hereditary Angioedema Market: https://www.delveinsight.com/report-store/hereditary-angioedema-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Bacterial Skin Diseases Market: https://www.delveinsight.com/report-store/bacterial-skin-diseases-market
• Bile Duct Neoplasm Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Chronic Obstructive Pulmonary Disease Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
• Hemophilia B Market: https://www.delveinsight.com/report-store/hemophilia-b-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Osteochondromas Market: https://www.delveinsight.com/report-store/osteochondromas-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• 3d Cardiac Mapping System Market: https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Burn Market: https://www.delveinsight.com/report-store/burn-market
• Chronic Rhinosinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Critical Limb Ischemia Market: https://www.delveinsight.com/report-store/critical-limb-ischemia-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Progressive Supranuclear Palsy Market: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
• Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Alpha Antitrypsin Market: https://www.delveinsight.com/report-store/alpha-1-antitrypsin-deficiency-a1atd-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Epithelioid Sarcoma Market: https://www.delveinsight.com/report-store/epithelioid-sarcoma-market
• Familial Amyloid Polyneuropathy Market: https://www.delveinsight.com/report-store/familial-amyloid-polyneuropathy-transthyretin-amyloidosis-corino-de-andrades-disease-market
• Graft Versus Host Disease Market: https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Anti-Depressant Drugs Market Expected to Experience Incremental Growth by 2030, According to DelveInsight | AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer, more here
News-ID: 3685063 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
